The ASXL1 gene is involved in histone modification and chromatin remodeling, and heterozygous mutations in this gene can lead to premature truncations, potentially resulting in myeloid leukemia and Bohring–Opitz syndrome [27,28]. This evidence concerns the gene ASXL1 and myeloid leukemia.